Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 1, 2011, Pages 67-72

  Nielsen, Vance G ^a   George, Shelley J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

carbon monoxide releasing molecule; fibrinolysis; hypothermia; thrombelastography

Indexed keywords

ANTICOAGULANT AGENT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; HYPOTHERMIA; IN VITRO STUDY; KINETICS; PLASMA; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; COAGULANTS; FIBRINOLYSIS; HUMANS; HYPOTHERMIA; ORGANOMETALLIC COMPOUNDS; THROMBELASTOGRAPHY;

EID: 78650780524     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283423534     Document Type: Article

References (22)

1. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: A review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65:951-960.
2. Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 2008; 108:71-77.
3. Romlin B, Petruson K, Nilsson K. Moderate superficial hypothermia prolongs bleeding time in humans. Acta Anaesthesiol Scand 2007; 51:198-201.
4. Shimokawa M, Kitaguchi K, KawaguchiM, Sakamoto T, KakimotoM, Furuya H. The influence of induced hypothermia for hemostatic function on temperature-adjusted measurements in rabbits. Anesth Analg 2003; 96:1209-1213.
5. Staikou C, Paraskeva A, Drakos E, Anastassopoulou I, Papaionnou E, Donta I, Kontos M. Impact of graded hypothermia on coagulation and fibrinolysis. J Surg Res (in press) doi:10.1016/j.jss.2009.07.037.c.
6. Martini WZ. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism 2007; 56:214-221.
7. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008; 65:535-543.
8. Watts DD, Trask A, Soeken K, Philip P, Dols SMT, Kaufmann C. Hypothermic coagulopathy in trauma: Effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998; 44:846-854.
9. Meng ZH, Wolberg AS, Monroe DM 3rd, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003; 55:886-891.
10. Wolberg AS, Meng ZH, Monroe DM 3rd, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56:1221-1228.
11. Dirkmann D, Hanke AA, Gorlinger K, Peters J. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 2008; 106:1627-1632.
12. Rundgren M, Engstrom M. A thromboelastometric evaluation of the effects of hypothermia on the coagulation system. Anesth Analg 2008; 107:1464-1468.
13. Ramaker AJ, Meyer P, van der Meer J, Struys MM, Lisman T, van Oeveren W, Hendriks HG. Effects of acidosis, alkalosis, hyperthermia and hypothermia on haemostasis: Results of point-of-care testing with the thromboelastography analyser. Blood Coagul Fibrinolysis 2009; 20:436-439.
14. Kheirabadi BS, Delgado AV, Dubick MA, Scherer MR, Fedyk CG, Holcome JB, Pusateri AE. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures. J Trauma 2007; 63:1079-1086.
15. Viuff D, Lauritzen B, Pusateri AE, Andersen S, Rojkjaer R, Johansson PI. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven). Br J Anaesth 2008; 101:324-331.
16. Bochicchio G, Kilbourne M, Kuehn R, Keledjian K, Hess J, Scalea T. Use of a modified chitosan dressing in a hypothermic coagulopathic grade V liver injury model. Am J Surg 2009; 198:617-622.
17. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 (CORM-2) increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and Factor VII deficient plasmas. Blood Coagul Fibrinolysis 2010; 21:41-45.
18. Nielsen VG, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin. Thromb Res 2010; 126:68-73.
19. Nielsen VG, Green P, Green M, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in diluted plasma. J Trauma (in press).
20. Nielsen VG, Cohen BM, Cohen E. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006; 17:75-81.
21. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 (CORM-2) decreases fibrinolysis in human plasma. Blood Coagul Fibrinolysis 2009; 20:448-455.
22. Coats T, Roberts I, Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2004:CD004896.